|
Video: What is a Stock Split?
|
|
NuCana is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by applying its ProTide technology to transform some of the prescribed chemotherapy agents, nucleoside analogs, into medicines. Utilizing its proprietary technology, Co. is developing new medicines, ProTides, designed to overcome main cancer resistance mechanisms and generate concentrations of anti-cancer metabolites in cancer cells. Co.'s ProTide candidates, Acelarin® and NUC-3373, are chemical entities derived from the nucleoside analogs gemcitabine and 5-fluorouracil, respectively, two chemotherapy agents. Co. is evaluating NUC-7738 in clinical trial for patients with solid tumors. According to our NuCana stock split history records, NuCana has had 1 split. | |
|
NuCana (NCNA) has 1 split in our NuCana stock split history database. The split for NCNA took place on April 16, 2024. This was a 1 for 25 reverse split, meaning for each 25 shares of NCNA owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 40 share position following the split.
When a company such as NuCana conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the NuCana stock split history from start to finish, an original position size of 1000 shares would have turned into 40 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into NuCana shares, starting with a $10,000 purchase of NCNA, presented on a split-history-adjusted basis factoring in the complete NuCana stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
09/29/2017 |
|
End date: |
05/06/2024 |
|
Start price/share: |
$459.25 |
|
End price/share: |
$3.88 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.16% |
|
Average Annual Total Return: |
-51.46% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$84.44 |
|
Years: |
6.61 |
|
|
|
Date |
Ratio |
04/16/2024 | 1 for 25 |
|
|